- Home
- VCEL vs NVVEW Comparison
VCEL vs NVVEW Comparison
Compare VCEL & NVVEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCEL
- NVVEW
- Stock Information
- Founded
- VCEL 1989
- NVVEW N/A
- Country
- VCEL United States
- NVVEW China
- Employees
- VCEL N/A
- NVVEW 12
- Industry
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- NVVEW Oil Refining/Marketing
- Sector
- VCEL Health Care
- NVVEW Energy
- Exchange
- VCEL Nasdaq
- NVVEW Nasdaq
- Market Cap
- VCEL 2.1B
- NVVEW N/A
- IPO Year
- VCEL 1997
- NVVEW 2020
- Fundamental
- Price
- VCEL $40.25
- NVVEW $0.02
- Analyst Decision
- VCEL Strong Buy
- NVVEW
- Analyst Count
- VCEL 8
- NVVEW 0
- Target Price
- VCEL $62.00
- NVVEW N/A
- AVG Volume (30 Days)
- VCEL 477.0K
- NVVEW N/A
- Earning Date
- VCEL 07-31-2025
- NVVEW N/A
- Dividend Yield
- VCEL N/A
- NVVEW N/A
- EPS Growth
- VCEL 521.85
- NVVEW N/A
- EPS
- VCEL 0.05
- NVVEW N/A
- Revenue
- VCEL $238,541,000.00
- NVVEW N/A
- Revenue This Year
- VCEL $23.03
- NVVEW N/A
- Revenue Next Year
- VCEL $24.52
- NVVEW N/A
- P/E Ratio
- VCEL $780.58
- NVVEW N/A
- Revenue Growth
- VCEL 14.80
- NVVEW N/A
- 52 Week Low
- VCEL $37.39
- NVVEW N/A
- 52 Week High
- VCEL $63.00
- NVVEW N/A
- Technical
- Relative Strength Index (RSI)
- VCEL 44.06
- NVVEW N/A
- Support Level
- VCEL $39.39
- NVVEW N/A
- Resistance Level
- VCEL $42.61
- NVVEW N/A
- Average True Range (ATR)
- VCEL 1.73
- NVVEW 0.00
- MACD
- VCEL -0.15
- NVVEW 0.00
- Stochastic Oscillator
- VCEL 24.16
- NVVEW 0.00
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About NVVEW Nuvve Holding Corp. Warrant
Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.